Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Daniel J Walker, Oren Mason, David B Clemow & Kathleen A Day. (2015) Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder. Postgraduate Medicine 127:7, pages 686-701.
Read now
Read now
David B. Clemow, Oren W. Mason, Elias H. Sarkis, Dustin D. Ruff, Brad D. Berman, Craig L. Donnelly, Adelaide S. Robb, Donna S. Holland, Kory J. Schuh, Janet M. Barnes & Andre B. Araujo. (2015) Atomoxetine monotherapy compared with combination therapy for the treatment of ADHD: a retrospective chart review study. Expert Review of Neurotherapeutics 15:11, pages 1353-1366.
Read now
Read now
Articles from other publishers (7)
Tsutomu Nagai, Tatsuya Kurihara, Hiroaki Koya, Yukako Nakano, Satoru Sugisawa, Takehiko Sambe, Keiko Kishimoto, Mari Kogo, Haruhisa Ota, Akira Iwanami & Naoki Uchida. (2022)
Identification of factors associated with the efficacy of atomoxetine in adult
attention‐deficit
/hyperactivity disorder
. Neuropsychopharmacology Reports 42:3, pages 249-255.
Crossref
Crossref
Suravi Patra, Naresh Nebhinani, Anand Viswanathan & Richard Kirubakaran. (2019) Atomoxetine for attention deficit hyperactivity disorder in children and adolescents with autism: A systematic review and meta‐analysis. Autism Research 12:4, pages 542-552.
Crossref
Crossref
David B. Clemow, Allen W. Nyhuis & Rebecca L. Robinson. (2016) Clinical Impact of Not Achieving Recommended Dose on Duration of Atomoxetine Treatment in Adults with Attention‐Deficit/Hyperactivity Disorder. CNS Neuroscience & Therapeutics 22:12, pages 970-978.
Crossref
Crossref
Charlotte L. Rae, Cristina Nombela, Patricia Vázquez Rodríguez, Zheng Ye, Laura E. Hughes, P. Simon Jones, Timothy Ham, Timothy Rittman, Ian Coyle-Gilchrist, Ralf Regenthal, Barbara J. Sahakian, Roger A. Barker, Trevor W. Robbins & James B. Rowe. (2016) Atomoxetine restores the response inhibition network in Parkinson’s disease. Brain 139:8, pages 2235-2248.
Crossref
Crossref
Linda A. Wietecha, David B. Clemow, Andrew S. Buchanan, Joel L. Young, Elias H. Sarkis & Robert L. Findling. (2016) Atomoxetine Increased Effect over Time in Adults with Attention‐Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double‐Blind, Placebo‐Controlled, Randomized Trials. CNS Neuroscience & Therapeutics 22:7, pages 546-557.
Crossref
Crossref
David B Clemow & Chris J Bushe. (2015) Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients. Journal of Psychopharmacology 29:12, pages 1221-1230.
Crossref
Crossref
Samaneh Kabul, Carlos Alatorre, Leslie B. Montejano, Amanda M. Farr & David B. Clemow. (2015) Real‐World Dosing Patterns of Atomoxetine in Adults with Attention‐Deficit/Hyperactivity Disorder. CNS Neuroscience & Therapeutics 21:12, pages 936-942.
Crossref
Crossref